Eric Coldwell Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
2.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
76.5%
Neutral
23.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Materials
Real Estate
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Healthcare Plans
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Materials
Specialty Chemicals
Real Estate
Diversified REIT
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $16 |
4%
downside
| 3 | +26% |
0
%
| 27 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $326 |
23%
upside
| 3 | +3.7% |
0
%
| 18 Feb ‘26 3 months ago |
|
|
|
Outperform
Initiated
| $48 |
29%
upside
| 1 | +2.8% |
0
%
| 12 Jan ‘26 5 months ago |
|
|
|
Outperform
Maintained
| $927 |
19%
upside
| 1 | +12% |
0
%
| 6 Nov ‘25 7 months ago |
|
|
|
Outperform
Upgraded
| $199 |
6%
upside
| 2 | -7.7% |
0
%
| 6 Nov ‘25 7 months ago |
|
|
|
Outperform
Upgraded
| $258 |
45%
upside
| 3 | -24% |
0
%
| 29 Oct ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $224 |
52%
upside
| 3 | -20% |
0
%
| 2 Sep ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| $194 |
4%
downside
| 3 | +3.6% |
0
%
| 25 Aug ‘25 9 months ago |
|
|
|
Neutral
Maintained
| $27 |
4%
downside
| 2 | – |
–
| 20 Aug ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $203 |
10%
downside
| 2 | +25% |
0
%
| 13 Aug ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $7 |
131%
upside
| 2 | -46% |
0
%
| 12 Aug ‘25 10 months ago |
|
|
|
Neutral
Maintained
| $490 |
5%
upside
| 2 | – |
–
| 23 Jul ‘25 10 months ago |
|